Although the evidence for radiotherapy is limited for MBC, current guidelines recommend adjuvant irradiation for tumor stage ≥ T2, for negative hormone receptor status, and in cases where axillary lymph nodes are involved [9]. The gene discussed is NR4A1; the disease is neoplasm.